FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172201105> ?p ?o ?g. }

• W2172201105 abstract "There is an on-going debate about whether to perform surgery on early stage localised prostate cancer and risk the common long term side effects such as urinary incontinence and erectile dysfunction. Alternatively these patients could be closely monitored and treated only in case of disease progression (active surveillance). The aim of this paper is to develop a decision-analytic model comparing the cost-utility of active surveillance (AS) and radical prostatectomy (PE) for a cohort of 65 year old men with newly diagnosed low risk prostate cancer.A Markov model comparing PE and AS over a lifetime horizon was programmed in TreeAge from a German societal perspective. Comparative disease specific mortality was obtained from the Scandinavian Prostate Cancer Group trial. Direct costs were identified via national treatment guidelines and expert interviews covering in-patient, out-patient, medication, aids and remedies as well as out of pocket payments. Utility values were used as factor weights for age specific quality of life values of the German population. Uncertainty was assessed deterministically and probabilistically.With quality adjustment, AS was the dominant strategy compared with initial treatment. In the base case, it was associated with an additional 0.04 quality adjusted life years (7.60 QALYs vs. 7.56 QALYs) and a cost reduction of €6,883 per patient (2011 prices). Considering only life-years gained, PE was more effective with an incremental cost-effectiveness ratio of €96,420/life year gained. Sensitivity analysis showed that the probability of developing metastases under AS and utility weights under AS are a major sources of uncertainty. A Monte Carlo simulation revealed that AS was more likely to be cost-effective even under very high willingness to pay thresholds.AS is likely to be a cost-saving treatment strategy for some patients with early stage localised prostate cancer. However, cost-effectiveness is dependent on patients' valuation of health states. Better predictability of tumour progression and modified reimbursement practice would support widespread use of AS in the context of the German health care system. More research is necessary in order to reliably quantify the health benefits compared with initial treatment and account for patient preferences." @default.
• W2172201105 created "2016-06-24" @default.
• W2172201105 creator A5024794927 @default.
• W2172201105 creator A5029530726 @default.
• W2172201105 creator A5047467702 @default.
• W2172201105 creator A5065546822 @default.
• W2172201105 date "2014-04-10" @default.
• W2172201105 modified "2023-10-07" @default.
• W2172201105 title "The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer" @default.
• W2172201105 cites W12770956 @default.
• W2172201105 cites W1482315162 @default.
• W2172201105 cites W1580867 @default.
• W2172201105 cites W1688472436 @default.
• W2172201105 cites W1965700776 @default.
• W2172201105 cites W1978444272 @default.
• W2172201105 cites W1980710500 @default.
• W2172201105 cites W1983145936 @default.
• W2172201105 cites W1988905458 @default.
• W2172201105 cites W1992768779 @default.
• W2172201105 cites W2004185507 @default.
• W2172201105 cites W2006291887 @default.
• W2172201105 cites W2011834196 @default.
• W2172201105 cites W2014639327 @default.
• W2172201105 cites W2019425393 @default.
• W2172201105 cites W2023317117 @default.
• W2172201105 cites W2030545473 @default.
• W2172201105 cites W2040664049 @default.
• W2172201105 cites W2052859221 @default.
• W2172201105 cites W2056553154 @default.
• W2172201105 cites W2059061584 @default.
• W2172201105 cites W2068748474 @default.
• W2172201105 cites W2070912263 @default.
• W2172201105 cites W2074571707 @default.
• W2172201105 cites W2076615237 @default.
• W2172201105 cites W2079907181 @default.
• W2172201105 cites W2084177425 @default.
• W2172201105 cites W2093212053 @default.
• W2172201105 cites W2095919110 @default.
• W2172201105 cites W2100762183 @default.
• W2172201105 cites W2106787323 @default.
• W2172201105 cites W2107225109 @default.
• W2172201105 cites W2110569728 @default.
• W2172201105 cites W2117419474 @default.
• W2172201105 cites W2121655616 @default.
• W2172201105 cites W2124392780 @default.
• W2172201105 cites W2126243421 @default.
• W2172201105 cites W2126659847 @default.
• W2172201105 cites W2130824567 @default.
• W2172201105 cites W2136829307 @default.
• W2172201105 cites W2143025931 @default.
• W2172201105 cites W2143457017 @default.
• W2172201105 cites W2143942491 @default.
• W2172201105 cites W2145221548 @default.
• W2172201105 cites W2149264750 @default.
• W2172201105 cites W2151855585 @default.
• W2172201105 cites W2156497611 @default.
• W2172201105 cites W2157123352 @default.
• W2172201105 cites W2162619388 @default.
• W2172201105 cites W2162661850 @default.
• W2172201105 cites W2162760026 @default.
• W2172201105 cites W2162923066 @default.
• W2172201105 cites W2169875394 @default.
• W2172201105 cites W2324196449 @default.
• W2172201105 cites W2399587218 @default.
• W2172201105 cites W4298870098 @default.
• W2172201105 doi "https://doi.org/10.1186/1472-6963-14-163" @default.
• W2172201105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4022451" @default.
• W2172201105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24721557" @default.
• W2172201105 hasPublicationYear "2014" @default.
• W2172201105 type Work @default.
• W2172201105 sameAs 2172201105 @default.
• W2172201105 citedByCount "31" @default.
• W2172201105 countsByYear W21722011052014 @default.
• W2172201105 countsByYear W21722011052015 @default.
• W2172201105 countsByYear W21722011052016 @default.
• W2172201105 countsByYear W21722011052017 @default.
• W2172201105 countsByYear W21722011052018 @default.
• W2172201105 countsByYear W21722011052019 @default.
• W2172201105 countsByYear W21722011052020 @default.
• W2172201105 countsByYear W21722011052021 @default.
• W2172201105 crossrefType "journal-article" @default.
• W2172201105 hasAuthorship W2172201105A5024794927 @default.
• W2172201105 hasAuthorship W2172201105A5029530726 @default.
• W2172201105 hasAuthorship W2172201105A5047467702 @default.
• W2172201105 hasAuthorship W2172201105A5065546822 @default.
• W2172201105 hasBestOaLocation W21722011051 @default.
• W2172201105 hasConcept C112930515 @default.
• W2172201105 hasConcept C121608353 @default.
• W2172201105 hasConcept C126322002 @default.
• W2172201105 hasConcept C126894567 @default.
• W2172201105 hasConcept C159110408 @default.
• W2172201105 hasConcept C177713679 @default.
• W2172201105 hasConcept C184834754 @default.
• W2172201105 hasConcept C2776235491 @default.
• W2172201105 hasConcept C2778531004 @default.
• W2172201105 hasConcept C2779466945 @default.
• W2172201105 hasConcept C2779951463 @default.
• W2172201105 hasConcept C2780192828 @default.
• W2172201105 hasConcept C2908647359 @default.
• W2172201105 hasConcept C29456083 @default.

• next